Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — Februar 2019

Planlagt Fastgjort Låst Flyttet Genmab
3.1k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • BulderB Offline
    BulderB Offline
    Bulder
    wrote on sidst redigeret af
    #1077

    Kunne se ud til at sakigake er på 6 mdr.men vi ved ikke om Janssen har fået det.

    1 Reply Last reply
    0
    • S Offline
      S Offline
      Sukkeralf
      wrote on sidst redigeret af
      #1078

      Just a moment...

      favicon

      (www.firstwordpharma.com)

      1 Reply Last reply
      0
      • SolsenS Offline
        SolsenS Offline
        Solsen
        wrote on sidst redigeret af
        #1079

        Hold da op. Så forstår jeg da ingenting af den handel BMY har gang i. Godt for Daras salg mener jeg tillige.

        1 Reply Last reply
        0
        • BulderB Offline
          BulderB Offline
          Bulder
          wrote on sidst redigeret af
          #1080

          Jeg troede ikke at det var allerede nu

          1 Reply Last reply
          0
          • Helge_LarsenPI-redaktørH Offline
            Helge_LarsenPI-redaktørH Offline
            Helge_LarsenPI-redaktør
            wrote on sidst redigeret af
            #1081

            Enig Solsen.

            1 Reply Last reply
            0
            • SolsenS Offline
              SolsenS Offline
              Solsen
              wrote on sidst redigeret af
              #1082

              Jeg har gravet meget i det. Men kom frem til 2022 på grundlag af mange artikler.

              1 Reply Last reply
              0
              • BulderB Offline
                BulderB Offline
                Bulder
                wrote on sidst redigeret af
                #1083

                Så får de nok en patentsag på halsen 😉

                1 Reply Last reply
                0
                • H Offline
                  H Offline
                  Hamming
                  wrote on sidst redigeret af
                  #1084

                  Just a moment...

                  favicon

                  (journals.lww.com)

                  1 Reply Last reply
                  0
                  • H Offline
                    H Offline
                    Hamming
                    wrote on sidst redigeret af
                    #1085

                    Godt overblik

                    1 Reply Last reply
                    0
                    • Helge_LarsenPI-redaktørH Offline
                      Helge_LarsenPI-redaktørH Offline
                      Helge_LarsenPI-redaktør
                      wrote on sidst redigeret af
                      #1086

                      Suverænt link. Tak Hamming.

                      1 Reply Last reply
                      0
                      • P Offline
                        P Offline
                        peter12
                        wrote on sidst redigeret af
                        #1087

                        Mere om Revlimid http://www.gabionline.net/Generics/News/Alvogen-receives-European-approval-for-generic-lenalidomide

                        1 Reply Last reply
                        0
                        • BulderB Offline
                          BulderB Offline
                          Bulder
                          wrote on sidst redigeret af
                          #1088

                          Flere af disse patenter ser ud til at udløbe i 2020 https://www.drugs.com/availability/generic-revlimid.html

                          1 Reply Last reply
                          0
                          • BulderB Offline
                            BulderB Offline
                            Bulder
                            wrote on sidst redigeret af
                            #1089

                            Mystisk: The patents on Revlimid’s ‘last-to-expire’ key patents, according to C
                            elgene, are only due to expire in the US in 2027 and in Europe in 2024.

                            1 Reply Last reply
                            0
                            • SolsenS Offline
                              SolsenS Offline
                              Solsen
                              wrote on sidst redigeret af
                              #1090

                              Der kan være meget forskel på lande og verdensdele. Men det bliver et hullet tæppe som tiden går. Så vi ikke forleden "Doctor Reddys" der opgav - sikkert imod betaling fra CELG (Husker ikke navnet)

                              1 Reply Last reply
                              0
                              • SolsenS Offline
                                SolsenS Offline
                                Solsen
                                wrote on sidst redigeret af
                                #1091

                                CELG har gjort alt for at forlænge patentet og tillige købt konkurrenter til at opgive eller udsætte launch.

                                1 Reply Last reply
                                0
                                • BulderB Offline
                                  BulderB Offline
                                  Bulder
                                  wrote on sidst redigeret af
                                  #1092

                                  Så nu bliver de nødt til at købe Genmab? 😉

                                  1 Reply Last reply
                                  0
                                  • E Offline
                                    E Offline
                                    E_L
                                    wrote on sidst redigeret af
                                    #1093

                                    Mike Thompson in good Dara mood today https://twitter.com/mtmdphd/status/1095658187859132416 https://twitter.com/mtmdphd/status/1095658194779676672

                                    1 Reply Last reply
                                    0
                                    • P Offline
                                      P Offline
                                      peter12
                                      wrote on sidst redigeret af
                                      #1094

                                      Endnu mere om Revlimid http://www.taipeitimes.com/News/biz/archives/2017/09/09/2003678067

                                      1 Reply Last reply
                                      0
                                      • P Offline
                                        P Offline
                                        peter12
                                        wrote on sidst redigeret af
                                        #1095

                                        Upon the expiration or loss of patent protection for a product, or upon the “at-risk” launch by a manufacturer of a generic version of one of our products, we can quickly lose a significant portion of our sales of that product. In addition, as additional competitors enter the market, our patented products may face increased competition or pricing pressure http://q4live.s22.clientfiles.s3-website-us-east-1.amazonaws.com/728481125/files/doc_financials/2018/b0b91209-0f73-447c-93ab-9027fb4c6bbf.pdf

                                        1 Reply Last reply
                                        0
                                        • P Offline
                                          P Offline
                                          peter12
                                          wrote on sidst redigeret af
                                          #1096

                                          Celgene skriver en del om det i det
                                          dokument, hvis man søger på "Our products may face competition"

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger